Quality of Life of Hypertensive Patients Undergoing Chronic Disease Management Program during the COVID-19 Pandemic

Widya Astuty Lolo; Gayatri Citraningtyas; Deby Afriani Mpila; Heri Wijaya; Sandeep Poddar

doi:10.21109/kesmas.v17i4.6224

Quality of Life of Hypertensive Patients Undergoing Chronic Disease Management Program during the COVID-19 Pandemic

Widya Astuty Lolo, Gayatri Citraningtyas, Deby Afriani Mpila, Heri Wijaya, Sandeep Poddar

Abstract

The COVID-19 pandemic has restricted some common activities for hypertensive patients undergoing the Chronic Disease Management Program/Program Pengelolaan Penyakit Kronis in primary health care, decreasing the quality of life. This study aimed to measure the quality of life of hypertensive patients undergoing the Chronic Disease Management Program at primary health care of Manado City, North Sulawesi Province, Indonesia, during the COVID-19 pandemic and determine the factors influencing hypertension such as sex, age, education, employment status, monthly income and duration of hypertension. This cross-sectional study was carried out on 150 hypertensive patients randomly sampled at primary health care from June to September 2021. The data were analyzed using the Mann-Whitney test. The quality of life of non-complicated hypertensive patients was higher than those with complications. The utility value and the visual analog scale of hypertensive patients with and without complications were 0.808±0.13 and 80.2±8.16 and 0.761±0.17 and 75.1±7.56, respectively. The quality of life of hypertensive patients without complication is better than that of hypertensive patients with complication.

Keywords

Chronic Disease Management Program; COVID-19; hypertension; noncommunicable disease; quality of life

Full Text:

PDF

References

1. Badan Penelitian dan Pengembangan Kesehatan. Hasil Utama Riskesdas 2018. Jakarta: Kementerian Kesehatan Republik Indonesia; 2018.

2. Hikmawati I, Setiyabudi R. HIPERTENSI DAN DIABETES MILITUS SEBAGAI PENYAKIT PENYERTA UTAMA COVID-19 DI INDONESIA HYPERTENSION AND DIABETES MELLITUS AS COVID-19 COMORBIDITIES IN INDONESIA. In PROSIDING SEMINAR NASIONAL LPPM UMP 2020. Purwokerto: LEMBAGA PENELITIAN DAN PENGABDIAN PADA MASYARAKAT UNIVERSITAS MUHAMMADIYAH PURWOKERTO. 2020; 95-100.

3. Zhou X, Zhu J, Xu T. Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors. Clinical and Experimental Hypertension. 2020; 42 (7): 656-60.

4. Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017; 15 (2): 127-137.

5. EuroQol Research Foundation. EQ-5D-5L: About. Rotterdam: EuroQol Research Foundation; 2022.

6. Purba FD, Hunfeld JAM, Iskandarsyah A, Fitriana TS, Sadarjoen SS, Ramos-Goñi JM, et al. The Indonesian EQ-5D-5L Value Set. PharmacoEconomics. 2017; 35 (11): 1153-65.

7. Sari A, Lestari NY, Perwitasari DA. VALIDASI ST EUROPEAN QUALITY OF LIFE-5 DIMENSIONS (EQ-5D) VERSI INDONESIA PADA PASIEN HIPERTENSI DI PUSKESMAS KOTAGEDE II YOGYAKARTA. PharmaCiana. 2015; 5 (2).

8. Tondok SB, Watu E, Wahyuni W. Validitas instrumen European Qualitiy of Life (EQ-5D-5L) Versi Indonesia untuk menilai kualitas hidup penderita tuberkulosis. Holistik Jurnal Kesehatan. 2021; 15 (2): 267-73.

9. Klocek M, Kawecka-Jaszcz K. Quality of Life in Hypertensive Patients. Health-Related Quality of Life in Cardiovascular Patients. 2012; 9-29.

10. Saleem F, Hassali MA, Shafie AA. A cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in Pakistan. Health Expect. 2014; 17 (3): 388-95.

11. Chen L, Zong Y, Wei T, Sheng X, Shen W, Li J, et al. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study. BMC Public Health. 2015; 15: 383.

12. Ariffin AI, Sukandar H, Defi IR, Sofiatin Y, Roesly RMA. Quality of Life among Patients with Hypertension Type 1 in Jatinangor 2014. J Hypertens. 2015; 33: 36-42.

13. Yuswar MA, Susanti R, Az-zahra NS. Pengukuran Kualitas Hidup Pasien Pengguna Antihipertensi dengan European Quality of Life 5 Dimensions (EQ5D) Questionnaire dan Visual Analog Scale (VAS). J. Sains Kes. 2019; 2 (2): 93-9.

14. Khoirunnisa SM, Akhmad AD. Quality of Life of Patients with Hypertension in Primary Health Care in Bandar Lampung. Indonesian Journal of Pharmacy. 2019; 30 (4): 309-15.

15. Sari A, Lolita L, Fauzia F. PENGUKURAN KUALITAS HIDUP PASIEN HIPERTENSI DI PUSKESMAS MERGANGSAN YOGYAKARTA MENGGUNAKAN EUROPEAN QUALITY OF LIFE 5 DIMENSIONS (EQ5D) QUESTIONNAIRE DAN VISUAL ANALOG SCALE (VAS). Jurnal Ilmiah Ibnu Sina. 2017; 2 (1): 1-12.

16. Kustanti N. Kualitas Hidup Lansia Dengan Hipertensi Di Wilayah Kerja Puskesmas Karangmalang Kabupaten Sragen [Undergraduate Thesis]. Surakarta: Universitas Muhammadiyah Surakarta; 2012.

17. Xu RH, Cheung AWL, Wong ELY. Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China. Patient Prefer Adherence. 2017; 11: 1565-1572.

18. Majnarić LT, Martinović I, Šabanović Š, Rudan S, Babič F, Wittlinger T. The Effect of Hypertension Duration and the Age of Onset on CV Risk Factors Expression in Perimenopausal Women. International Journal of Hypertension. 2019; 2019.

19. Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapour-Shahkolaei F. Medication Adherence and its Related Factors in Patients with Type II Diabetes. J Educ Community Health. 2016; 2 (4): 3-12.

20. Anggara FHD, Prayitno N. Faktor-Faktor Yang Berhubungan Dengan Tekanan Darah Di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012. Jurnal Ilmiah Kesehatan. 2013; 5(1): 20–25.

21. Fuadina A, Arifin M. The Correlation Between Stress And Hypertension In Society. In Strategi, Tantangan dan Peluang Tenaga Kesehatan di Era Society 5.0. Pekalongan: LPPM Universitas Muhammadiyah Pekajangan Pekalongan; 2019.

Tseng CD, Yen AMF, Chiu SYH, Chen LS, Chen HH, Chang SH. A Predictive Model for Risk of Prehypertension and Hypertension and Expected Benefit After Population-Based Life-Style Modification (KCIS No. 24). American Journal of Hypertension. 2012; 25 (2): 171-9.

23. Hamida N, Ulfa M, Haris RNH, Endarti D, Wiedyaningsih C. Pengukuran Kualitas Hidup Pasien Program Pengelolaan Penyakit Kronis (Prolanis) di Puskesmas Menggunakan Instrumen EQ-5D-5L. Majalah Farmaseutik. 2019; 15 (2): 67-74.

24. Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can J Cardiol. 2018; 34 (5): 575-584.

DOI: http://dx.doi.org/10.21109/kesmas.v17i4.6224